A novel presenilin 2 mutation (V393M) in early-onset dementia with profound language impairment.

European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies
Suzanne Granhøj LindquistJørgen Erik Nielsen

Abstract

Mutations in the Presenilin 2 gene (PSEN2) are rare causes of Alzheimer's disease (AD). Pathogenic mutations in the genes associated with autosomal dominant inherited AD have been shown to alter processing of the amyloid precursor protein (APP) resulting in a relative increase of the amount of Abeta42 peptide. We present a patient with neuropathologically confirmed early-onset AD characterized by profound language impairment. The patient was heterozygous for a novel missense mutation in exon 11 of the PSEN2 gene leading to a predicted amino acid substitution from valine to methionine in position 393, a conserved residue. However, in vitro expression of PSEN2 V393M cDNA did not result in detectable increase of the secreted Abeta42/40 peptide ratio. The mutation was not found in 384 control individuals tested. The possible pathogenic nature of the mutation is not clarified. We discuss the limitations of functional PSEN2 studies and the challenges associated with genetic counselling of family members at risk.

References

May 15, 1996·Analytical Biochemistry·H W KlafkiM Staufenbiel

❮ Previous
Next ❯

Citations

Apr 9, 2010·Brain : a Journal of Neurology·Suman JayadevThomas D Bird
Nov 4, 2010·Journal of Geriatric Psychiatry and Neurology·Lynn M BekrisDebby W Tsuang
Mar 29, 2014·Oxidative Medicine and Cellular Longevity·Marco Antonio Meraz-RíosVictoria Campos-Peña
Nov 10, 2018·Journal of Alzheimer's Disease : JAD·Haowei JiangMorgan Newman
Apr 28, 2010·Expert Review of Neurotherapeutics·Siddhartha Mondragón-RodríguezMark A Smith
Jun 20, 2020·Neurotoxicity Research·Md Tanvir KabirMohamed M Abdel-Daim

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.